Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Clinical trial NCT07493447 · RECRUITING

Trial details

NCT number: NCT07493447
Sponsor: Eben Rosenthal
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Meningioma Glioblastoma Acoustic Neuroma Brain Cancer Pituitary Adenoma

Start date: 2026-07-01
Primary completion: 2030-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.